Literature DB >> 7670781

Sleep intensity in fibromyalgia: focus on the microstructure of the sleep process.

A M Drewes1, K D Nielsen, S J Taagholt, K Bjerregård, L Svendsen, J Gade.   

Abstract

Alpha electroencephalography (EEG) predominance has been described during sleep in patients suffering from the fibromyalgia syndrome (FMS). However, EEG power density in the lower frequency bands probably better reflects the restorative functions of sleep. This study was conducted to describe the energy in all frequency bands in the sleep EEG. Ambulatory sleep recordings were performed on 12 women with FMS and 14 control women. Epochs were classified according to standard criteria. Moreover, all 2-s segments (n = 287,355) of the EEG in non-rapid-eye-movement (NREM) 2-4 sleep were subjected to frequency analysis using autoregressive modelling. Frequency bands were: delta (0.5-3.5 Hz), theta (3.5-8 Hz), alpha (8-12 Hz), sigma (12-14.5 Hz) and beta (14.5-25 Hz). In patients with FMS, there was a predominance of EEG power in the higher frequency bands [two-way analysis of variance (ANOVA), alpha: P = 0.043; sigma: P = 0.004] at the expense of the lower frequencies (ANOVA, delta: P = 0.005; theta: P = 0.008). The same trends were obtained for the individual sleep cycles. The calculations of total delta power in the time domain showed an exponentially declining curve in healthy subjects, but a flatter decline in FMS. The decreased power in the low-frequency range might reflect a disorder in homoeostatic and circadian mechanisms during sleep and may contribute to daytime symptoms in patients with fibromyalgia.

Entities:  

Mesh:

Year:  1995        PMID: 7670781     DOI: 10.1093/rheumatology/34.7.629

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  17 in total

Review 1.  The role of sleep in pain and fibromyalgia.

Authors:  Ernest H S Choy
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

2.  Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome.

Authors:  M M Heitkemper; K C Cain; W Deechakawan; A Poppe; S-E Jun; R L Burr; M E Jarrett
Journal:  Neurogastroenterol Motil       Date:  2012-04-03       Impact factor: 3.598

3.  Evaluating Evidence for the Role of Sleep in Fibromyalgia: A Test of the Sleep and Pain Diathesis Model.

Authors:  Nancy A Hamilton; Mindy Pressman; Teresa Lillis; Ruthann Atchley; Cynthia Karlson; Natalie Stevens
Journal:  Cognit Ther Res       Date:  2012-12-01

Review 4.  Polysomnographic characteristics in nonmalignant chronic pain populations: A review of controlled studies.

Authors:  Martin F Bjurstrom; Michael R Irwin
Journal:  Sleep Med Rev       Date:  2015-04-08       Impact factor: 11.609

Review 5.  Fibromyalgia and sleep in animal models: a current overview and future directions.

Authors:  Cristina Frange; Camila Hirotsu; Helena Hachul; Paula Araujo; Sergio Tufik; Monica L Andersen
Journal:  Curr Pain Headache Rep       Date:  2014

Review 6.  [Fibromyalgia].

Authors:  M Späth
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

Review 7.  Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review.

Authors:  Michael Browning; Paul Fletcher; Michael Sharpe
Journal:  Psychosom Med       Date:  2011-01-07       Impact factor: 4.312

8.  Power spectral analysis of sleep EEG in twins discordant for chronic fatigue syndrome.

Authors:  Roseanne Armitage; Carol Landis; Robert Hoffmann; Martha Lentz; Nathaniel Watson; Jack Goldberg; Dedra Buchwald
Journal:  J Psychosom Res       Date:  2008-11-25       Impact factor: 3.006

9.  Relationship between sleep and pain in adolescents with juvenile primary fibromyalgia syndrome.

Authors:  Margaret N Olsen; David D Sherry; Kathleen Boyne; Rebecca McCue; Paul R Gallagher; Lee J Brooks
Journal:  Sleep       Date:  2013-04-01       Impact factor: 5.849

10.  Decrease of Serum IGF-1 Level is Not Associated With Obstructive Sleep Apnea in Fibromyalgia Patients.

Authors:  Emrullah Hayta; Ayşe Altun Okşaşoğlu
Journal:  Arch Rheumatol       Date:  2016-10-19       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.